Tenax Therapeutics Inc. | Mutual Funds
Mutual Funds that own Tenax Therapeutics Inc.
Vanguard Extended Market Index Fund
12,200
0.86%
0
0%
07/31/2018
DFA US Small Cap Portfolio
6,712
0.48%
6,712
0%
04/30/2018
DFA US Targeted Value Portfolio
5,938
0.42%
5,938
0%
04/30/2018
Fidelity Spartan Extended Market Index Fund
1,502
0.11%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
627
0.04%
0
0%
09/06/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
188
0.01%
0
0%
06/30/2018
BlackRock Master Extended Market Index Series
94
0.01%
0
0%
01/31/2018
Fidelity Spartan Total Market Index Fund
69
0.01%
0
0%
07/31/2018
BlackRock (Japan) US Small Cap Growth Equity Open Mother Fund
56
0%
-157
0%
09/20/2016
RIM Global - CC Bioscience
0
0%
-294
0%
06/30/2017
| Address |
ONE Copley Parkway
Morrisville North Carolina 27560
United States
|
|
Employees
|
- |
| Website |
http://www.tenaxthera.com |
| Updated |
07/08/2019 |
| Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing, and commercializing novel therapeutic products for the critical care market. Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC. |
